Abstract
Purpose
Previous studies have determined optimal cut points (CPs) for the classification of pain severity as mild, moderate, or severe using only the Brief Pain Inventory (BPI) or the BPI in conjunction with a quality of life (QOL) tool. The purpose of our study was to determine the optimal CPs based on correlation with only QOL outcomes.
Methods
We conducted an analysis of 298 patients treated with radiation therapy for painful bone metastases on a phase III randomized trial. Prior to treatment, patients provided their worst pain score on a scale of 0 (no pain) to 10 (worst possible pain), as well as completed the European Organization of Cancer Research and Treatment (EORTC) QOL Questionnaire Bone Metastases module (QLQ-BM22) and the EORTC QOL Questionnaire Core-15 Palliative (QLQ-C15-PAL). Optimal CPs were determined to be those that yielded the largest F ratio for the between category effect on each subscale of the QLQ-BM22 and QLQ-C15-PAL using the multivariate analysis of variance (MANOVA).
Results
The two largest F ratios for Wilk’s λ, Pillai’s Trace, and Hotelling’s Trace were for CPs 5,6 and 5,7. Combining both, the optimal CPs to differentiate between mild, moderate, and severe pain were 5 and 7. Pain scores of 1–5, 6, and 7–10 were classified as mild, moderate, and severe, respectively. Patients with severe pain experienced greater functional interference and poorer QOL when compared to those with mild pain.
Conclusion
Our results suggest that, based on the impact of pain on QOL measures, pain scores should be classified as follows: 1–5 as mild pain, 6 as moderate pain, and 7–10 as severe pain. Optimal CPs vary depending on the type of outcome measurement used.
Similar content being viewed by others
References
Culleton S, Kwok S, Chow E (2011) Radiotherapy for pain. Clin Oncol 23(6):399–406. doi:10.1016/j.clon.2010.11.011
Cleeland CS (1984) The impact of pain on the patient with cancer. Cancer 54(Suppl 11):2635–2641
. Arias F, Arraras JI, Asin G, Zarandona U, Mora I, Errasti M, Barrado M, Campo M, Visus I, Dominguez MA (2015) To what extent does radiotherapy improve the quality of life of patients with bone metastasis? Am J Clin Oncol
Woo A, Lechner B, Fu T, Wong CS, Chiu N, Lam H, Pulenzas N, Soliman H, DeAngelis C, Chow E (2015) Cut points for mild, moderate, and severe pain among cancer and non-cancer patients: a literature review. Ann Palliat Med 4(4):176–183. doi:10.3978/j.issn.2224-5820.2015.09.04
World Health Organization (1990) Cancer pain relief and palliative care: report of the WHO expert committee on cancer pain relief and active supportive care. Technical Report Series 804, Geneva
World Health Organization (1996) Cancer pain relief: with a guide to opioid availability. Geneva
Cancer Care Ontario (2012) Cancer-related pain management. Program in evidence-based care evidence-based series no.: 16–2 [education and information 2011 Sep]. Cancer Care Ontario, Toronto (ON)
Serlin RC, Mendoza TR, Nakamura Y, Edwards KR, Cleeland CS (1995) When is cancer pain mild, moderate or severe? Grading pain severity by its interference with function. Pain 61(2):277–284
Paul SM, Zelman DC, Smith M, Miaskowski C (2005) Categorizing the severity of cancer pain: further exploration of the establishment of cutpoints. Pain 113(1–2):37–44
Li KK, Harris K, Hadi S, Chow E (2007) What should be the optimal cut points for mild, moderate, and severe pain? J Palliat Med 10(6):1338–1346
Kalyadina SA, Ionova TI, Ivanova MO, Uspenskaya OS, Kishtovich AV, Mendoza TR, Guo H, Novik A, Cleeland CS, Wang XS (2008) Russian brief pain inventory: validation and application in cancer pain. J Pain Symptom Manag 35(1):95–102
Ferreira KA, Teixeira MJ, Mendonza TR, Cleeland CS (2011) Validation of brief pain inventory to Brazilian patients with pain. Support Care Cancer 19(4):505–511. doi:10.1007/s00520-010-0844-7
. Chow E, Ding K, Parulekar WR, Wong RK, van der Linden YM, Roos D, Hartsell WF, Hoskin P, Wu JS, Nabid A, Ong F, van Tienhoven G, Babington S, Demas WF, Wilson CF, Brundage M, Zhu L, Meyer RM (2015) Revisiting classification of pain from bone metastases as mild, moderate, or severe based on correlation with function and quality of life. Supp Care Cancer
Chow E, Meyer RM, Ding K, Nabid A, Chabot P, Wong P, Ahmed S, Kuk J, Dar AR, Mahmud A, Fairchild A, Wilson CF, JS W, Dennis K, Brundage M, DeAngelis C, Wong RK (2015) Dexamethasone in the prophylaxis of radiation-induced pain flare after palliative radiotherapy for bone metastases: a double-blind, randomised placebo-controlled, phase 3 trial. Lancet Oncol 16(15):1463–1472. doi:10.1016/S1470-2045(15)00199-0
Cleeland CS, Ryan KM (1994) Pain assessment: global use of the brief pain inventory. Ann Acad Med Singap 23(2):129–138
Chow E, Hird A, Velikova G, Johnson C, Dewolf L, Bezjak A, Wu J, Shafiq J, Sezer O, Kardamakis D, Linden YV, Ma B, Castro M, Arnalot PF, Ahmedzai S, Clemons M, Hoskin P, Yee A, Brundage M, Bottomley A, EORTC Quality of Life Group; Collaboration for Cancer Outcomes Research and Evaluation (2009) The European Organisation for Research and Treatment of Cancer quality of life questionnaire for patients with bone metastases: the EORTC QLQ-BM22. Eur J Cancer 45(7):1146–1152. doi:10.1016/j.ejca.2008.11.013
Groenvold M, Petersen MA, Aaronson NK, Arraras JI, Blazeby JM, Bottomley A, Fayers PM, de Graeff A, Hammerlid E, Kaasa S, Sprangers MA, Bjorner JB, EORTC Quality of Life Group (2006) The development of the EORTC QLQ-C15-PAL: a shortened questionnaire for cancer patients in palliative care. Eur J Cancer 42(1):55–64
Acknowledgments
This study was supported by the NCIC CTG’s programmatic grants from the Canadian Cancer Society Research Institute. We thank the participation of all the patients and the research teams.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
None
Rights and permissions
About this article
Cite this article
McDonald, R., Ding, K., Chow, E. et al. Classification of painful bone metastases as mild, moderate, or severe using both EORTC QLQ-C15-PAL and EORTC QLQ-BM22. Support Care Cancer 24, 4871–4878 (2016). https://doi.org/10.1007/s00520-016-3341-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00520-016-3341-9